- AU$68.83m
- AU$52.18m
- AU$10.32m
- 63
- 25
- 64
- 51
Annual balance sheet for ImpediMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 19.7 | 19.7 | 40.7 | 45.7 | 24.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.51 | 4.6 | 4.38 | 4.38 | 3.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 25.4 | 25.6 | 46.7 | 51.9 | 29.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.01 | 1.03 | 0.418 | 1.95 | 1.45 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 33.1 | 34.2 | 58.7 | 68.7 | 47 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.11 | 8.13 | 7.24 | 5.85 | 4.66 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.7 | 8.69 | 7.66 | 7.86 | 6.24 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 27.4 | 25.5 | 51 | 60.9 | 40.7 |
| Total Liabilities & Shareholders' Equity | 33.1 | 34.2 | 58.7 | 68.7 | 47 |
| Total Common Shares Outstanding |